Skip to main navigation Skip to search Skip to main content

Exploiting macrophage functions to find novel therapies for KMT2a:MLLT3 infant leukaemia

Project Details

StatusActive
Effective start/end date1/10/25 → 30/09/28

Funding

  • Blood Cancer UK (Bloodwise): £299,966.63